A Journey Into Participation Patterns Among Metastatic Prostate Cancer Patients

NCT06009549 · tracked via the Priya Life Science USA tracker

Sponsor

Power Life Sciences Inc.

Phase

Observational

Started

2024-09

Last updated

2023-08-24

Condition(s) studied

Metastatic Prostate Cancer

Study summary

Taking part in clinical trials usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups.

This research will admit a wide range of data on the clinical study experience of metastatic prostate cancer patients to determine which factors prevail in limiting a patient's ability to join or finish a trial.

It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future patients with metastatic prostate cancer.

Eligibility

Sex

MALE

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Patient is at least 18 years of age * Diagnosis of metastatic prostate cancer * Ability to understand and the willingness to sign a written informed consent document Exclusion Criteria: * Enrolled in another research study * Patients with psychiatric illness/social situations that would limit compliance with study requirements * Inability to provide written informed consent

Primary outcome measure(s)

Number of patients who decide to participate in a metastatic prostate cancer clinical research — 3 months
Rate of patients who remain in metastatic prostate cancer clinical research to trial completion — 12 months

Trial sites (1)

Facility	City	Region	Status
Power Life Sciences	San Francisco	California

More Power Life Sciences Inc. trials in the USA

Insights Into Participating in Clinical Studies for Anorexia Starting soon

Navigating the Clinical Research Process for Mild Cognitive Impairment Starting soon

Delving Into Borderline Personality Disorder Clinical Trial Experiences Starting soon

Exploring Clinical Study Experiences of People With Post Traumatic Stress Disorder Starting soon

Revealing Engagement Patterns Among Hepatic Encephalopathy Patients Starting soon

Other trials for the same condition

A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer Recruiting

First-in-Human Study to Evaluate AZD8359 STEAP2 TCE in Participants With Prostate Cancer Recruiting

A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or Metastatic Prostate Cancer Recruiting

Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer Recruiting

Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06009549 on ClinicalTrials.gov ↗ ← All trials in the USA